查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092008

脊髓幫浦市場－2026-2032年全球市場預測

Spinal Pumps Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，脊椎幫浦市場將成長至 4.1043 億美元，複合年成長率為 3.26%。

主要市場統計數據
基準年 2025 3.2785億美元
預計年份：2026年 3.3795億美元
預測年份 2032 4.1043億美元
複合年成長率 (%) 3.26%

脊髓泵，也稱為鞘內藥物輸送系統，是植入式醫療設備，旨在將藥物直接輸送到脊髓周圍的腦脊髓液。它主要用於治療慢性疼痛和嚴重痙攣，特別適用於口服或全身性治療效果不佳、耐受性差或副作用難以接受的情況。透過將藥物輸送到脊髓腔（藥物的作用部位），脊髓幫浦與全身給藥相比，可減少藥物暴露量，同時在專科醫生的指導下實現更精準的症狀管理。

脊髓幫浦市場的發展趨勢受到臨床對難治性癌痛、非癌性慢性疼痛、多發性硬化症相關痙攣、腦性麻痹、脊髓損傷以及其他需要長期治療的神經系統疾病日益成長的關注。其應用與保險公司政策、外科手術基礎設施、藥物管理、醫療設備監測和病患教育密切相關，同時也與神經外科、疼痛醫學、復健、腫瘤學和安寧療護等領域的臨床路徑息息相關。監管、植入安全性、感染預防、程序設定精確度和藥物相容性仍然是臨床決策的核心因素，這使得脊髓幫浦成為神經調控和植入式藥物傳遞領域中一個尤其注重實證醫學的細分市場。

脊椎泵領域的變革性變化

隨著複雜疼痛和痙攣的治療模式轉向更個人化、多學科和以結果為導向的方法轉變，脊髓幫浦治療領域正經歷著變革。臨床醫生擴大對那些透過傳統方法無法獲得充分鎮痛的患者儘早評估鞘內治療。同時，他們正在實施更嚴格的篩檢方案、心理評估、實驗性程序和長期隨訪，以提高治療的安全性和療效的持久性。

人工智慧對脊髓幫浦的累積影響

人工智慧正開始對脊髓幫浦領域產生影響，其主要途徑並非自主實施治療，而是提供決策支援、最佳化臨床工作流程、進行預測分析。在植入前評估中，人工智慧工具可輔助分析結構化和非結構化臨床數據，例如用藥史、影像報告、合併症、功能評估和既往治療反應，從而幫助對患者進行分層，並識別與治療成功和併發症風險相關的因素。這些工具在臨床醫師的指導下，並在既定的倫理、監管和檢驗框架內作為輔助手段使用時，才能發揮最大價值。

關於脊椎泵的關鍵區域見解

在亞太地區，隨著主要經濟體中神經系統疾病管理、癌症治療和先進疼痛管理服務的擴展，脊髓幫浦的重要性日益凸顯。日本、韓國、澳洲、中國和印度的脊髓泵普及率各不相同，其應用受到專科醫生資源、醫保報銷系統、醫院基礎設施以及對鞘內治療難治性疼痛和痙攣的認知等因素的影響。雖然都市區的三級醫療機構通常是主要的使用場所，但農村和醫療資源匱乏地區則面臨神經外科手術能力不足以及長期藥物補充物流的挑戰。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東協地區，脊髓幫浦的引進主要集中在私人醫療體系發展迅速、神經內科、腫瘤科和疼痛管理服務較為完善的國家的三級醫療機構。由於成員國在報銷制度、專科醫生培訓和植入後補充醫療基礎設施方面存在顯著差異，區域差異十分明顯。在東協醫療體系內，建立可擴展的教育和轉診網路對於提高病患識別率和長期管理至關重要。

主要國家脊髓幫浦分析

美國擁有世界上最成熟的脊髓幫浦臨床應用環境之一，這得益於其先進的疼痛管理、神經外科、復健、腫瘤和安寧療護服務。臨床應用受患者選擇標準、保險公司審核、鴉片類藥物使用管理和長期替代療法等因素的影響。在加拿大，公共醫療體系展現了高水準的專業技術，但不同地區的醫療服務可近性卻存在差異。在墨西哥，脊髓泵在主要都市區醫院和私立專科醫療中心的應用正在逐步推進，其中經濟承受能力和保險報銷發揮著至關重要的作用。

為行業領導者提供的實用建議

行業領導者應優先考慮循證醫學證據的獲取、臨床教育和服務設計，而不僅僅是關注器械種植。更有力的真實世界證據，例如病患選擇、功能性結果、藥物減量、併發症預防和長期生活品質等方面，能夠增強臨床醫師的信心，並提高保險公司的接受度。訓練項目應涵蓋植入技術、程序設定、藥物替代安全、導管故障排除、感染預防以及戒斷症狀和過量用藥的緊急應變。

脊髓幫浦分析的調查方法

分析脊髓幫浦的調查方法應結合二手資料研究、一手專家檢驗和結構化資料的檢驗。二手資料研究應包括同行評審的臨床文獻、監管文件、臨床指南、醫療技術評估、不利事件資料庫、公共衛生資訊來源以及與鞘內給藥、慢性疼痛、嚴重痙攣、神經調控和植入式醫療設備相關的醫療保健政策出版物。

結論：脊髓幫浦在標靶疼痛和痙攣治療的應用

脊髓幫浦在難治性疼痛和嚴重痙攣的治療中發揮特殊但重要的臨床作用。其價值在於標靶鞘內藥物輸注、多學科患者篩選和持續隨訪，這些因素有助於改善患者症狀的合理管理，並在某些情況下減少對全身性治療的依賴。脊髓幫浦的應用受臨床證據、監管、保險報銷、外科手術經驗、藥物替代系統和病患教育等因素的影響。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 脊髓幫浦市場：依產品類型分類

  • 植入式脊髓泵
  • 外置脊髓泵

第8章：脊髓幫浦市場：依治療類型分類

  • 疼痛管理泵
  • 痙攣管理泵
  • 用於聯合治療的泵

第9章：脊髓幫浦市場：依藥物類型分類

  • 鴉片類藥物
  • 肌肉鬆弛劑
  • 局部麻醉劑
  • 非鴉片類鎮痛藥

第10章 脊髓幫浦市場：依技術分類

  • 可程式設計泵浦
  • 恆速泵浦
  • 連接幫浦

第11章：脊椎幫浦市場：按應用領域分類

  • 慢性疼痛管理
  • 痙攣管理
  • 腫瘤學
  • 神經病變

第12章：脊椎幫浦市場：按地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章：脊髓幫浦市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章 脊椎幫浦市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Atlas Pain Care
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Daradia
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • IPSC
  • Medtronic plc
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-A77F2EE7AB0F

The Spinal Pumps Market is projected to grow by USD 410.43 million at a CAGR of 3.26% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 327.85 million
Estimated Year [2026] USD 337.95 million
Forecast Year [2032] USD 410.43 million
CAGR (%) 3.26%

Spinal pumps, also known as intrathecal drug delivery systems, are implantable medical devices designed to deliver medications directly into the cerebrospinal fluid around the spinal cord. They are used primarily in chronic pain management and severe spasticity where oral or systemic therapies are inadequate, poorly tolerated, or associated with unacceptable adverse effects. By administering therapy at the intrathecal site of action, spinal pumps can support lower drug exposure compared with systemic dosing while enabling more targeted symptom control under specialist supervision.

The spinal pumps landscape is shaped by rising clinical attention to refractory cancer pain, non-cancer chronic pain, multiple sclerosis-related spasticity, cerebral palsy, spinal cord injury, and other neurological conditions requiring long-term therapy. Adoption is closely linked to neurosurgery, pain medicine, rehabilitation, oncology, and palliative care pathways, as well as payer policies, surgical infrastructure, refill management, device surveillance, and patient education. Regulatory oversight, implant safety, infection prevention, programming accuracy, and medication compatibility remain central to clinical decision-making, making this a highly evidence-driven segment of neuromodulation and implantable drug delivery.

Transformative Shifts in the Spinal Pumps Landscape

The spinal pumps landscape is undergoing transformative shifts as care models move toward more personalized, multidisciplinary, and outcomes-oriented management of complex pain and spasticity. Clinicians are increasingly evaluating intrathecal therapy earlier for carefully selected patients who do not achieve adequate relief with conventional approaches, while also applying stricter screening protocols, psychological assessment, trialing procedures, and long-term follow-up to improve safety and therapeutic durability.

Another major shift is the growing emphasis on opioid stewardship and targeted drug delivery. In many health systems, concerns over systemic opioid exposure have intensified interest in therapies that can reduce systemic medication burden when clinically appropriate. At the same time, device management is becoming more structured, with greater focus on refill adherence, programming protocols, catheter integrity, pump replacement planning, and adverse event monitoring. Hospitals and ambulatory specialty centers are also standardizing infection-control procedures and perioperative pathways to reduce complications associated with implantable systems.

Digital enablement is also influencing the landscape. Electronic health records, remote care coordination, and device data documentation are helping clinical teams track dosing changes, refill schedules, patient-reported outcomes, and complication signals. As spinal pumps require lifelong management after implantation, integration between surgeons, pain specialists, rehabilitation physicians, nurses, pharmacists, and caregivers is becoming a critical differentiator in quality of care.

Cumulative Impact of Artificial Intelligence on Spinal Pumps

Artificial intelligence is beginning to influence spinal pumps through decision support, clinical workflow optimization, and predictive analytics rather than autonomous therapy delivery. In pre-implant evaluation, AI-enabled tools can help analyze structured and unstructured clinical data, including medication history, imaging reports, comorbidities, functional assessments, and prior treatment response, to support patient stratification and identify factors associated with therapy success or complication risk. These tools are most valuable when used as clinician-supervised aids within established ethical, regulatory, and validation frameworks.

AI can also strengthen longitudinal management of intrathecal drug delivery by helping identify missed refill risks, unusual dose escalation patterns, potential adverse event clusters, and documentation inconsistencies. Natural language processing may support extraction of patient-reported symptoms and functional outcomes from clinical notes, while predictive models may assist in scheduling proactive follow-up for patients at higher risk of withdrawal, overdose, infection, catheter malfunction, or therapy discontinuation. In hospital operations, AI-driven scheduling and inventory analytics can improve coordination of refill appointments, implant procedures, medication preparation, and replacement planning.

The cumulative impact of AI will depend on data quality, interoperability, cybersecurity, algorithm transparency, and clinical validation. Because spinal pumps involve high-risk implantable therapy and potent intrathecal medications, AI adoption must prioritize explainability, human oversight, auditability, and compliance with medical device software and data protection regulations.

Key Regional Insights for Spinal Pumps

Asia-Pacific is gaining importance in spinal pumps as neurological disease management, cancer care, and advanced pain services expand across major economies. Japan, South Korea, Australia, China, and India demonstrate varying levels of access, with adoption influenced by specialist availability, reimbursement structures, hospital infrastructure, and awareness of intrathecal therapy for refractory pain and spasticity. Urban tertiary centers are typically the main access points, while rural and underserved areas face barriers related to neurosurgical capacity and long-term refill logistics.

North America remains a highly developed region for spinal pumps, supported by established pain medicine, neurosurgery, oncology, rehabilitation, and palliative care networks. The United States and Canada have mature clinical pathways for intrathecal drug delivery, though access is shaped by payer authorization, opioid stewardship policies, patient selection requirements, and the availability of trained implanting physicians. Device follow-up, refill adherence, and complication management are key quality priorities across the region.

Latin America shows selective adoption concentrated in major hospitals and specialist centers, particularly in larger economies with advanced private and public healthcare institutions. Brazil and Mexico are notable markets for complex pain and neurological care, while affordability, reimbursement variation, and specialist distribution continue to influence access. Europe benefits from strong specialty care systems, regulatory oversight, and clinical experience in neuromodulation and intrathecal therapy. Western European countries typically have more structured reimbursement and referral pathways, while parts of Eastern Europe face uneven access to implantable therapy services.

The Middle East is developing spinal pump capabilities through investment in tertiary care, medical tourism, oncology services, and neurological rehabilitation, particularly in high-income Gulf countries. Access is more limited in lower-resource settings where implant costs, specialist training, and long-term medication management remain barriers. Africa has the most variable access, with spinal pump use concentrated in select urban referral hospitals; broader adoption is constrained by limited neurosurgical infrastructure, affordability challenges, device maintenance requirements, and continuity-of-care limitations.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, spinal pump adoption is primarily linked to tertiary hospitals in countries with expanding private healthcare capacity and growing neurology, oncology, and pain medicine services. Regional variation is significant, as reimbursement, specialist training, and post-implant refill infrastructure differ widely across member states. For ASEAN health systems, scalable education and referral networks are essential to improve appropriate patient identification and long-term management.

The GCC shows stronger readiness for advanced implantable therapies due to investment in specialty hospitals, rehabilitation centers, and high-acuity chronic disease management. Spinal pumps are supported by access to specialist care in major urban centers, though sustainable outcomes depend on standardized refill protocols, patient follow-up, and multidisciplinary coordination. The European Union provides a comparatively structured environment for spinal pumps, with established medical device regulation, health technology assessment processes, and mature specialist pathways in many member countries. However, access still varies by national reimbursement policies, clinical guidelines, and regional hospital capacity.

BRICS countries present a mixed but strategically important landscape. China and India have large patient populations and expanding tertiary care infrastructure, while Brazil, Russia, and South Africa demonstrate access concentrated in advanced centers. Across BRICS, affordability, reimbursement, clinician training, and long-term service capacity remain decisive. G7 countries generally have the most mature ecosystems for spinal pumps, supported by advanced surgical infrastructure, established regulatory systems, specialist networks, and stronger post-market surveillance expectations. NATO member countries overlap substantially with North American and European systems, where defense-related rehabilitation expertise, spinal cord injury care, and advanced hospital networks can indirectly support intrathecal therapy capabilities, though national healthcare policy remains the principal determinant of patient access.

Key Country Insights for Spinal Pumps

The United States has one of the most established clinical environments for spinal pumps, driven by advanced pain management, neurosurgery, rehabilitation, oncology, and palliative care services. Clinical use is shaped by patient selection standards, payer review, opioid stewardship, and long-term refill management. Canada demonstrates strong specialist capabilities within publicly funded care structures, though regional access may differ due to geography, referral pathways, and procedural capacity. Mexico shows adoption in major urban hospitals and private specialty centers, with affordability and reimbursement playing central roles.

Brazil is a key Latin American country for advanced pain and neurological care, with spinal pump access concentrated in large medical centers. The United Kingdom, Germany, France, Italy, and Spain have established European pathways for complex pain and spasticity management, supported by specialist hospitals and regulatory oversight, but access depends on national reimbursement criteria, local commissioning decisions, and clinical guideline implementation. Germany and France benefit from robust specialty infrastructure, while the United Kingdom emphasizes structured referral and public-sector evaluation. Italy and Spain show strong hospital-based expertise with regional variability. Russia has advanced tertiary capabilities in major cities, although access can vary across regions due to healthcare infrastructure differences.

China is expanding advanced neuromodulation and implantable therapy capacity through large tertiary hospitals, with demand influenced by neurological disease burden, cancer care needs, and modernization of specialty medicine. India is developing spinal pump use in leading urban centers, especially where pain medicine, neurosurgery, and rehabilitation services are integrated, while cost sensitivity and follow-up logistics remain important barriers. Japan has sophisticated medical technology infrastructure and an aging population that increases demand for chronic neurological and pain care, with adoption guided by regulatory, reimbursement, and specialist practice frameworks. Australia benefits from advanced specialist networks and structured healthcare governance, though geographic dispersion can complicate refill access for remote patients. South Korea combines strong hospital technology adoption with advanced neurological and surgical care, supporting selective use of spinal pumps in appropriate clinical settings.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation, clinical education, and service design rather than focusing solely on device placement. Stronger real-world evidence on patient selection, functional outcomes, medication reduction, complication prevention, and long-term quality of life can support clinician confidence and payer acceptance. Training programs should address implantation technique, programming, refill safety, catheter troubleshooting, infection prevention, and emergency management of withdrawal or overdose.

Manufacturers, providers, and care networks should strengthen multidisciplinary pathways that connect pain specialists, neurosurgeons, rehabilitation teams, oncologists, pharmacists, nurses, and primary care providers. Clear protocols for trialing, implantation, refills, dose adjustments, replacement timing, and adverse event escalation can reduce variability in outcomes. Patient and caregiver education is equally important, particularly around refill adherence, symptom monitoring, travel planning, and urgent warning signs.

Leaders should also invest in digital tools that improve scheduling, documentation, registry participation, and post-implant surveillance while maintaining cybersecurity and regulatory compliance. In emerging regions, partnership models that support clinician training, service-center development, and sustainable refill logistics can improve access without compromising safety. Above all, strategies should align with evidence-based medicine, ethical promotion, and transparent risk-benefit communication.

Research Methodology for Spinal Pumps Analysis

The research methodology for analyzing spinal pumps should combine secondary research, primary expert validation, and structured data triangulation. Secondary research includes peer-reviewed clinical literature, regulatory documents, clinical guidelines, health technology assessments, adverse event databases, public health sources, and healthcare policy publications related to intrathecal drug delivery, chronic pain, severe spasticity, neuromodulation, and implantable medical devices.

Primary research should include interviews with pain physicians, neurosurgeons, rehabilitation specialists, oncologists, palliative care experts, pharmacists, nurses, hospital procurement teams, payers, and device management professionals. These interviews help validate clinical adoption drivers, procedural barriers, reimbursement considerations, patient follow-up requirements, and regional access differences. Data triangulation should compare clinical evidence, regulatory signals, healthcare infrastructure indicators, and expert input to ensure balanced interpretation.

Quality control requires exclusion of unsupported claims, transparent source assessment, and careful differentiation between approved indications, off-label practices, and investigational applications. Given the safety-critical nature of spinal pumps, methodology should emphasize clinical validation, regulatory alignment, patient safety evidence, and geographic context without relying on speculative projections.

Conclusion: Spinal Pumps in Targeted Pain and Spasticity Care

Spinal pumps occupy a specialized but clinically significant role in the management of refractory pain and severe spasticity. Their value lies in targeted intrathecal drug delivery, multidisciplinary patient selection, and sustained follow-up that can improve symptom control for appropriate patients while reducing reliance on systemic therapy in selected cases. Adoption is influenced by clinical evidence, regulatory oversight, reimbursement, surgical expertise, refill infrastructure, and patient education.

The landscape is evolving through stronger opioid stewardship, improved care coordination, digital workflow tools, and the early integration of AI-supported analytics. Regional and country-level differences remain substantial, with mature access in advanced specialty care systems and more selective adoption in emerging healthcare environments. Industry progress will depend on evidence-based practice, safety-centered innovation, trained care teams, and sustainable service models that support patients across the full implant lifecycle.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Spinal Pumps Market, by Product Type

  • 7.1. Introduction
  • 7.2. Implantable Spinal Pumps
  • 7.3. External Spinal Pumps

8. Spinal Pumps Market, by Therapy Type

  • 8.1. Introduction
  • 8.2. Pain Management Pumps
  • 8.3. Spasticity Management Pumps
  • 8.4. Combination Therapy Pumps

9. Spinal Pumps Market, by Drug Type

  • 9.1. Introduction
  • 9.2. Opioids
  • 9.3. Muscle Relaxants
  • 9.4. Local Anesthetics
  • 9.5. Non-Opioid Analgesics

10. Spinal Pumps Market, by Technology

  • 10.1. Introduction
  • 10.2. Programmable Pumps
  • 10.3. Fixed-Rate Pumps
  • 10.4. Connected Pumps

11. Spinal Pumps Market, by Application

  • 11.1. Introduction
  • 11.2. Chronic Pain Management
  • 11.3. Spasticity Management
  • 11.4. Oncology
  • 11.5. Neurological Disorders

12. Spinal Pumps Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Spinal Pumps Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. Spinal Pumps Market, by Country

  • 14.1. China
  • 14.2. United States
  • 14.3. Japan
  • 14.4. India
  • 14.5. Germany
  • 14.6. United Kingdom
  • 14.7. Australia
  • 14.8. France
  • 14.9. South Korea
  • 14.10. Italy
  • 14.11. Canada
  • 14.12. Russia
  • 14.13. Brazil
  • 14.14. Mexico
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Atlas Pain Care
  • 16.3. B. Braun Melsungen AG
  • 16.4. Boston Scientific Corporation
  • 16.5. Daradia
  • 16.6. Flowonix Medical Inc.
  • 16.7. Fresenius Kabi AG
  • 16.8. IPSC
  • 16.9. Medtronic plc
  • 16.10. Teleflex Incorporated
  • 16.11. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPINAL PUMPS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL SPINAL PUMPS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL SPINAL PUMPS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL SPINAL PUMPS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SPINAL PUMPS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL SPINAL PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL SPINAL PUMPS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL SPINAL PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL SPINAL PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL SPINAL PUMPS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL SPINAL PUMPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTABLE SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTERNAL SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXTERNAL SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTERNAL SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PAIN MANAGEMENT PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PAIN MANAGEMENT PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PAIN MANAGEMENT PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SPASTICITY MANAGEMENT PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPASTICITY MANAGEMENT PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPASTICITY MANAGEMENT PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMBINATION THERAPY PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COMBINATION THERAPY PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMBINATION THERAPY PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OPIOIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MUSCLE RELAXANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MUSCLE RELAXANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MUSCLE RELAXANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-OPIOID ANALGESICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-OPIOID ANALGESICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-OPIOID ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PROGRAMMABLE PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PROGRAMMABLE PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PROGRAMMABLE PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FIXED-RATE PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FIXED-RATE PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FIXED-RATE PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONNECTED PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONNECTED PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONNECTED PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CHRONIC PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CHRONIC PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CHRONIC PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SPASTICITY MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SPASTICITY MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SPASTICITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. NATO SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. NATO SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NATO SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. NATO SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NATO SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. NATO SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. G7 SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. G7 SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. G7 SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. G7 SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. G7 SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. G7 SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GCC SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GCC SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. GCC SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. GCC SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. CHINA SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. JAPAN SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. JAPAN SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. JAPAN SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. JAPAN SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. JAPAN SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. JAPAN SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. INDIA SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 150. INDIA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. INDIA SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. INDIA SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. INDIA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. INDIA SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. GERMANY SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. GERMANY SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GERMANY SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GERMANY SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. GERMANY SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. GERMANY SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED KINGDOM SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED KINGDOM SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED KINGDOM SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED KINGDOM SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED KINGDOM SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED KINGDOM SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. AUSTRALIA SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. AUSTRALIA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AUSTRALIA SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. AUSTRALIA SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AUSTRALIA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. AUSTRALIA SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. FRANCE SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. FRANCE SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. FRANCE SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. FRANCE SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. FRANCE SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. FRANCE SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. SOUTH KOREA SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. SOUTH KOREA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. SOUTH KOREA SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. SOUTH KOREA SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. SOUTH KOREA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. SOUTH KOREA SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. ITALY SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. ITALY SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ITALY SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ITALY SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ITALY SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. ITALY SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. CANADA SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. CANADA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. CANADA SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CANADA SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. CANADA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. RUSSIA SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. RUSSIA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. RUSSIA SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. RUSSIA SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. RUSSIA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. RUSSIA SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. BRAZIL SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. BRAZIL SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. BRAZIL SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRAZIL SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. BRAZIL SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. BRAZIL SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. MEXICO SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. MEXICO SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MEXICO SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. MEXICO SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. MEXICO SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. MEXICO SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. SPAIN SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. SPAIN SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. SPAIN SPINAL PUMPS MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. SPAIN SPINAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. SPAIN SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. SPAIN SPINAL PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL SPINAL PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 222. GLOBAL SPINAL PUMPS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025